Management of acute renal failure in the elderly patient: A clinician's guide

Drugs and Aging

Volumn 25, Issue 6, 2008, Pages 455-476

  Cheung, Ching M ^a   Ponnusamy, Arvind ^a   Anderton, John G ^a  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

Elderly; Renal failure, general

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALLOPURINOL; AMINOGLYCOSIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; AZATHIOPRINE; BICARBONATE; CALCIUM CHLORIDE; CIMETIDINE; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; FENOLDOPAM; FUROSEMIDE; GLUCONATE CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MANNITOL; METHOTREXATE; METHYLPREDNISOLONE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PLACEBO; POLYSTYRENESULFONATE CALCIUM; SALBUTAMOL; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; AGING; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG DOSE TITRATION; DRUG MEGADOSE; ECHOGRAPHY; ELECTROLYTE URINE LEVEL; GERIATRIC PATIENT; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HYPERKALEMIA; HYPERTENSION; INCIDENCE; INTERSTITIAL NEPHRITIS; INTESTINE ISCHEMIA; KIDNEY ARTERY STENOSIS; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; LOW DRUG DOSE; LUNG EDEMA; LUNG HEMORRHAGE; METABOLIC ACIDOSIS; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL SUPPORT; PLASMAPHERESIS; POTASSIUM INTAKE; POTASSIUM RESTRICTION; PRIORITY JOURNAL; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RENAL REPLACEMENT THERAPY; RENOVASCULAR DISEASE; RESPIRATORY FAILURE; REVIEW; SEPSIS; SHOCK; SIDE EFFECT; SURVIVAL RATE; SYSTEMIC VASCULITIS; TACHYCARDIA; ULTRASOUND; UNSPECIFIED SIDE EFFECT; UREMIA; URINALYSIS; URINE OSMOLALITY; URINE VOLUME; VASOCONSTRICTION;

AGED; AGING; CLINICAL TRIALS AS TOPIC; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS;

EID: 44949199186     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825060-00002     Document Type: Review

References (171)

1. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983; 74 (2): 243-8
2. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 2003; 14 (8): 2178-87
3. Bellomo R, Ronco C, Kellum JA, et al., and the ADQI work-group. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12
4. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11 (2): R31
5. Orimo H. Reviewing the definition of elderly. Nippon Ronen Igakkai Zasshi 2006; 43 (1): 27-34
6. Pascual J, Orofino L, Liano F, et al. Incidence and prognosis of acute renal failure in older patients. J Am Geriatr Soc 1990; 38 (1): 25-30
7. Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993; 306 (6876): 481-3
8. McLachlan M, Wasserman P. Changes in sizes and distensibility of the aging kidney. Br J Radiol 1981; 54 (642): 488-91
9. Thomas SE, Anderson S, Gordon KL, et al. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 1998; 9 (2): 231-42
10. Abrass CK, Adcox MJ, Raugi GJ. Aging-associated changes in renal extracellular matrix. Am J Pathol 1995; 146 (3): 742-52
11. Hoy WE, Douglas-Denton RN, Hughson MD, et al. A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 2003; (83): S31-7
12. Hollenberg NK, Adams DF, Solomon HS. Senescence and renal vasculature in normal man. Circ Res 1974; 34: 309-16
13. Barton M, Lattmann T, d'Uscio LV, et al. Inverse regulation of endothelin-1 and nitric oxide metabolites in tissue with aging: implications for the age-dependent increase of cardiorenal disease. J Cardiovasc Pharmacol 2000; 36 (5 Suppl. 1): S153-6
14. Thompson MM, Oyama TT, Kelly FJ, et al. Activity and responsiveness of the renin-angiotensin system in the aging rat. Am J Physiol Regul Integr Comp Physiol 2000; 279 (5): R1787-94
15. Castellani S, Ungar A, Cantini C, et al. Excessive vasoconstriction after stress by the aging kidney: inadequate prostaglandin modulation of increased endothelin activity. J Lab Clin Med 1998; 132 (3): 186-94
16. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41 (1): 1-12
17. Bleyer AJ, Shemanski LR, Burke GL, et al. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 2000; 57 (5): 2072-9
18. Sands JM. Urine-concentrating ability in the aging kidney. Sci Aging Knowledge Environ 2003; 2003 (24): PE15
19. Davidman M, Olson P, Kohen J, et al. Iatrogenic renal disease. Arch Intern Med 1991; 151 (9): 1809-12
20. Kohli HS, Bhaskaran MC, Muthukumar T, et al. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant 2000; 15 (2): 212-7
21. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996; 50 (3): 811-8
22. Pascual J, Liano F. Causes and prognosis of acute renal failure in the very old: Madrid Acute Renal Failure Study Group. J Am Geriatr Soc 1998; 46 (6): 721-5
23. Kenney WL, Chiu P. Influence of age on thirst and fluid intake. Med Sci Sports Exerc 2001; 33 (9): 1524-32
24. van Kraaij DJ, Jansen RW, Gribnau FW, et al. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction. Drugs Aging 2000; 16 (4): 289-300
25. Piraino AJ. Managing medication in the elderly. Hosp Pract (Minneap) 1995; 30 (6): 59-64
26. Baraldi A, Ballestri M, Rapana R, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant 1998; 13 Suppl. 7: 25-9
27. Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 1987; 32 (1): 1-12
28. Huerta C, Castellsague J, Varas-Lorenzo C, et al. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 2005; 45 (3): 531-9
29. Motola D, Vaccheri A, Silvani MC, et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol 2004; 60 (10): 731-8
30. Pilotto A, Franceschi M, Leandro G, et al. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies. Drugs Aging 2003; 20 (9): 701-10
31. Johnson AG, Simons LA, Simons J, et al. Non-steroidal antiinflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol 1993; 35 (5): 455-9
32. Jones AC, Berman P, Doherty M. Non-steroidal anti-inflammatory drug usage and requirement in elderly acute hospital admissions. Br J Rheumatol 1992; 31 (1): 45-8
33. Fraenkel L, Wittink DR, Concato J, et al. Informed choice and the widespread use of antiinflammatory drugs. Arthritis Rheum 2004; 51 (2): 210-4
34. Cheung CM, Shaheen N, Shurrab AE, et al. Use and effects of ACE inhibitors and angiotensin II receptor blockers in patients with atherosclerotic renovascular disease (ARVD) [abstract no. RA4583]. Renal Association Conference; 2004 Sep; London
35. Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc 2002; 50 (7): 1297-300
36. Kalra PA, Mamtora H, Holmes AM, et al. Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. Q J Med 1990; 77 (282): 1013-8
37. Bridoux F, Hazzan M, Pallot JL, et al. Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis. Nephrol Dial Transplant 1992; 7 (2): 100-4
38. Kalra PA, Kumwenda M, MacDowall P, et al. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ 1999; 318 (7178): 234-7
39. Liano F, Junco E, Pascual J, et al. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings: the Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998; 66: S16-24
40. Brivet FG, Kleinknecht DJ, Loirat P, et al. Acute renal failure in intensive care units: causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 1996; 24 (2): 192-8
41. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351 (2): 159-69
42. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14 (8): 2199-210
43. Myers BD, Chui F, Hilberman M, et al. Transtubular leakage of glomerular filtrate in human acute renal failure. Am J Physiol 1979; 237 (4): F319-25
44. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 1979; 58 (5): 362-76
45. Anderson RJ, Linas SL, Berns AS, et al. Nonoliguric acute renal failure. N Engl J Med 1977; 296 (20): 1134-8
46. Dixon BS, Anderson RJ. Nonoliguric acute renal failure. Am J Kidney Dis 1985; 6 (2): 71-80
47. Rahman SN, Conger JD. Glomerular and tubular factors in urine flow rates of acute renal failure patients. Am J Kidney Dis 1994; 23 (6): 788-93
48. Liangos O, Rao M, Balakrishnan VS, et al. Relationship of urine output to dialysis initiation and mortality in acute renal failure. Nephron Clin Pract 2005; 99 (2): c56-60
49. Cronan JJ. Contemporary concepts in imaging urinary tract obstruction. Radiol Clin North Am 1991; 29: 527-42
50. Naidich JB, Rackson ME, Mossey RT, et al. Nondilated obstructive uropathy: percutaneous nephrostomy performed to reverse renal failure. Radiology 1986; 160 (3): 653-7
51. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31-41
52. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130 (6): 461-70
53. Pedone C, Corsonello A, Incalzi RA. Estimating renal function in older people: a comparison of three formulas. Age Ageing 2006; 35 (2): 121-6
54. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40 (2): 221-6
55. Ginsberg JM, Chang BS, Matarese RA, et al. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983; 309 (25): 1543-6
56. Schwab SJ, Christensen RL, Dougherty K, et al. Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med 1987; 147 (5): 943-4
57. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002; 62 (6): 2223-9
58. Swaminathan S, Shah SV. New insights into nephrogenic systemic fibrosis. J Am Soc Nephrol 2007; 18: 2636-43
59. Haas M, Spargo BH, Wit EJ, et al. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis 2000; 35 (3): 433-47
60. Kingswood JC, Banks RA, Tribe CR, et al. Renal biopsy in the elderly: clinicopathological correlations in 143 patients. Clin Nephrol 1984; 22 (4): 183-7
61. Ferro G, Dattolo P, Nigrelli S, et al. Clinical pathological correlates of renal biopsy in elderly patients. Clin Nephrol 2006; 65 (4): 243-7
62. Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002; 137 (9): 744-52
63. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition: the Mini Nutritional Assessment. Clin Geriatr Med 2002; 18 (4): 737-57
64. Druml W. Nutritional management of acute renal failure. J Ren Nutr 2005; 15 (1): 63-70
65. Marik PE, Iglesias J. Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria: NORASEPT II Study Investigators. Am J Med 1999; 107 (4): 387-90
66. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356 (9248): 2139-43
67. Friedrich JO, Adhikari N, Herridge MS, et al. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142 (7): 510-24
68. Lauschke A, Teichgraber UK, Frei U, et al. 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006; 69 (9): 1669-74
69. Power DA, Duggan J, Brady HR. Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Clin Exp Pharmacol Physiol Suppl 1999; 26: S23-8
70. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997; 12 (12): 2592-6
71. Cantarovich F, Rangoonwala B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004; 44 (3): 402-9
72. Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288 (20): 2547-53
73. Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol 1981; 15 (2): 90-6
74. Shaw SG, Weidmann P, Hodler J, et al. Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 1987; 80 (5): 1232-7
75. Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994; 45 (6): 1731-8
76. Sward K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004; 32 (6): 1310-5
77. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis: Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997; 336 (12): 828-34
78. Lewis J, Salem MM, Chertow GM, et al. Atrial natriuretic factor in oliguric acute renal failure: Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 2000; 36 (4): 767-74
79. Mathur VS, Swan SK, Lambrecht LJ, et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999; 27 (9): 1832-7
80. Halpenny M, Rushe C, Breen P, et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002; 19 (1): 32-9
81. Caimmi PP, Pagani L, Micalizzi E, et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003; 17 (4): 491-4
82. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003; 290 (17): 2284-91
83. Kim YK, Yoo JH, Woo JS, et al. Effect of pentoxifylline on ischemic acute renal failure in rabbits. Ren Fail 2001; 23 (6): 757-72
84. Kim YK, Choi TR, Kwon CH, et al. Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits. Ren Fail 2003; 25 (6): 909-22
85. Shifow AA, Naidu MU, Kumar KV, et al. Effect of pentoxifylline on cyclosporine-induced nephrotoxicity in rats. Indian J Exp Biol 2000; 38 (4): 347-52
86. Lin F, Cordes K, Li L, et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003; 14 (5): 1188-99
87. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004; 15 (7): 1794-804
88. Star RA. Treatment of ARF. Kidney Int 1998; 54: 1817-31
89. Himmelfarb J, Tolkoff RN, Chandran P, et al. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1998; 9 (2): 257-66
90. Parker RA, Himmelfarb J, Tolkoff-Rubin N, et al. Prognosis of patients with acute renal failure requiring dialysis: results of a multicenter study. Am J Kidney Dis 1998; 32 (3): 432-43
91. Schiffl H, Lang SM, Konig A, et al. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344 (8922): 570-2
92. Vinsonneau C, Camus C, Combes A, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006; 368 (9533): 379-85
93. Lameire N, Hoste E, Van LA, et al. Pathophysiology, causes, and prognosis of acute renal failure in the elderly. Ren Fail 1996; 18 (3): 333-46
94. Gentric A, Cledes J. Immediate and long-term prognosis in acute renal failure in the elderly. Nephrol Dial Transplant 1991; 6 (2): 86-90
95. Schiffl H. Renal recovery from acute tubular necrosis requiring renal replacement therapy: a prospective study in critically ill patients. Nephrol Dial Transplant 2006; 21 (5): 1248-52
96. Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM 1996; 89 (6): 415-21
97. Spurney RF, Fulkerson WJ, Schwab SJ. Acute renal failure in critically ill patients: prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med 1991; 19 (1): 8-11
98. Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60 (3): 1154-63
99. Liano F, Felipe C, Tenorio MT, et al. Long-term outcome of acute tubular necrosis: a contribution to its natural history. Kidney Int 2007; 71 (7): 679-86
100. Chertow GM, Soroko SH, Paganini EP, et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int 2006; 70 (6): 1120-6
101. Chertow GM, Lazarus JM, Paganini EP, et al. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis: the Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol 1998; 9 (4): 692-8
102. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16 (11): 3365-70
103. Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005; 9 (6): R700-9
104. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294 (7): 813-8
105. Fiaccadori E, Lombardi M, Leonardi S, et al. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol 1999; 10 (3): 581-93
106. Brivet F, Delfraissy JF, Balavoine JF, et al. Acute kidney failure: age is not a factor in the prognosis. Nephrologie 1983; 4 (1): 14-7
107. Lameire N, Matthys E, Vanholder R, et al. Causes and prognosis of acute renal failure in elderly patients. Nephrol Dial Transplant 1987; 2 (5): 316-22
108. Mehta RL, McDonald B, Gabbai F, et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med 2002; 113 (6): 456-61
109. Khan IH, Catto GR, Edward N, et al. Acute renal failure: factors influencing nephrology referral and outcome. Q J Med 1997; 90 (12): 781-5
110. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med 1990; 150 (6): 1237-42
111. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: a prospective trial. Ann Intern Med 1989; 110 (2): 119-24
112. Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 1991; 157 (1): 49-58
113. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1989; 320 (3): 143-9
114. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47 (1): 254-61
115. Cigarroa RG, Lange RA, Williams RH, et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86 (6 Pt 1): 649-52
116. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343 (3): 180-4
117. Mueller C, Seidensticker P, Buettner HJ, et al. Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration. Swiss Med Wkly 2005; 135 (19-20): 286-90
118. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291 (19): 2328-34
119. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40 (8): 1383-8
120. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003; 289 (5): 553-8
121. Durham JD, Caputo C, Dokko J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002; 62 (6): 2202-7
122. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40 (2): 298-303
123. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002; 89 (3): 356-8
124. Shah SJ, Hsu CY. Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study. Am J Med 2004; 117 (12): 948-52
125. Coyle LC, Rodriguez A, Jeschke RE, et al. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Am Heart J 2006; 151 (5): 1032-12
126. Webb JG, Pate GE, Humphries KH, et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J 2004; 148 (3): 422-9
127. Baker CS, Wragg A, Kumar S, et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 2003; 41 (12): 2114-8
128. Hoffmann U, Fischereder M, Kruger B, et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004; 15 (2): 407-10
129. Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362 (9384): 598-603
130. Alonso A, Lau J, Jaber BL, et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled materialtrials. Am J Kidney Dis 2004; 43 (1): 1-9
131. Pannu N, Manns B, Lee H, et al. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004; 65 (4): 1366-74
132. Liu R, Nair D, Ix J, et al. N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. J Gen Intern Med 2005; 20 (2): 193-200
133. Nallamothu BK, Shojania KG, Saint S, et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004; 117 (12): 938-47
134. Zagler A, Azadpour M, Mercado C, et al. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 2006; 151 (1): 140-5
135. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275 (19): 1489-94
136. Khanal S, Attallah N, Smith DE, et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med 2005; 118 (8): 843-9
137. Frank H, Werner D, Lorusso V, et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 2003; 60 (3): 176-82
138. Vogt B, Ferrari P, Schonholzer C, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111 (9): 692-8
139. Watts RA, Lane SE, Bentham G, et al. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000; 43 (2): 414-9
140. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004; 117 (1): 39-50
141. Jennette JC, Wilkman AS, Falk RJ. Diagnostic predictive value of ANCA serology. Kidney Int 1998; 53 (3): 796-8
142. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitic: EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998; 53 (3): 743-53
143. Shin JH, Pyo HJ, Kwon YJ, et al. Renal biopsy in elderly patients: clinicopathological correlation in 117 Korean patients. Clin Nephrol 2001; 56 (1): 19-26
144. Labeeuw M, Colon S, Caillette A, et al. Renal histological findings in elderly adults over 75 years of age. Contrib Nephrol 1993; 105: 147-51
145. Nachman PH, Hogan SL, Jennette JC, et al. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7 (1): 33-9
146. Cole E, Cattran D, Magil A, et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis: the Canadian Apheresis Study Group. Am J Kidney Dis 1992; 20 (3): 261-9
147. Mekhail TM, Hoffman GS. Long-term outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis. J Rheumatol 2000; 27 (5): 1237-40
148. Aasarod K, Iversen BM, Hammerstrom J, et al. Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000; 15 (5): 611-8
149. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116 (6): 488-98
150. De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52 (8): 2461-9
151. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349 (1): 36-44
152. Pusey CD, Rees AJ, Evans DJ, et al. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991; 40 (4): 757-63
153. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006; 17 (8): 2264-74
154. Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18 (7): 2180-8
155. Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41 (4): 776-84
156. Slot MC, Tervaert JW, Franssen CF, et al. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 2003; 63 (2): 670-7
157. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43 (5): 1021-32
158. Jayne D. Current attitudes to the therapy of vasculitis. Kidney Blood Press Res 2003; 26 (4): 231-9
159. Schwartz CJ, White TA. Stenosis of the renal artery: an unselected necropsy study. BMJ 1964; 2: 1415-21
160. Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull 2005; 73-74: 35-55
161. Scolari F, Ravani P, Pola A, et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 2003; 14 (6): 1584-90
162. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42 (2): 211-6
163. Thadhani RI, Camargo Jr CA, Xavier RJ, et al. Atheroembolic renal failure after invasive procedures: natural history based on 52 histologically proven cases. Medicine (Baltimore) 1995; 74 (6): 350-8
164. Gupta BK, Spinowitz BS, Charytan C, et al. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator. Am J Kidney Dis 1993; 21 (6): 659-62
165. Hyman BT, Landas SK, Ashman RF, et al. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987; 82 (6): 1233-7
166. Rudnick MR, Berns JS, Cohen RM, et al. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism. A critical review. Am J Kidney Dis 1994; 24 (4): 713-27
167. Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 2004; 19 (1): 8-11
168. Pusey CD, Saltissi D, Bloodworth L, et al. Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q J Med 1983; 52 (206): 194-211
169. Galpin JE, Shinaberger JH, Stanley TM, et al. Acute interstitial nephritis due to methicillin. Am J Med 1978; 65 (5): 756-65
170. Buysen JG, Houthoff HJ, Krediet RT, et al. Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant 1990; 5 (2): 94-9
171. Bagshaw SM. Epidemiology of renal recovery after acute renal failure. Curr Opin Crit Care 2006; 12 (6): 544-50